Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Semaglutide & heart failure | Deferred testing for low-risk chest pain patients | The first CVD drug of its kind
Monday, August 28, 2023
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

Weight loss drug semaglutide linked to multiple benefits for heart failure patients

Researchers think their findings, which were presented at ESC Congress 2023 and published in the New England Journal of Medicine, could "change the nature of the conversation about the role of obesity in HFpEF."

READ MORE >
cardiologist doctor physician patient black diverse hypertension
Share on Twitter Share on Facebook Share on Linkedin

Weight loss drug semaglutide linked to multiple benefits for heart failure patients

Share on Twitter Share on Facebook Share on Linkedin
cardiologist doctor physician patient black diverse hypertension
Researchers think their findings, which were presented at ESC Congress 2023 and published in the New England Journal of Medicine, could "change the nature of the conversation about the role of obesity in HFpEF."
READ MORE >

Deferred testing for low-risk chest pain patients is safe, limits unnecessary catheterizations

Once physicians confirm a patient's CAD risk is low, they can feel comfortable putting diagnostic testing on hold. 

READ MORE >
patient_exam_cardiology_covid_dr_cowan_beaumont.jpeg
Share on Twitter Share on Facebook Share on Linkedin

Deferred testing for low-risk chest pain patients is safe, limits unnecessary catheterizations

Share on Twitter Share on Facebook Share on Linkedin
patient_exam_cardiology_covid_dr_cowan_beaumont.jpeg
Once physicians confirm a patient's CAD risk is low, they can feel comfortable putting diagnostic testing on hold. 
READ MORE >

Texas researchers receive $1.14M to develop first CVD drug of its kind

If successful, the group's first-in-class medication would be able to target inflammation in CVD patients before it even occurs. 

READ MORE >
A heart attack is caused when one of the coronary arteries becomes blocked with a clot.
Share on Twitter Share on Facebook Share on Linkedin

Texas researchers receive $1.14M to develop first CVD drug of its kind

Share on Twitter Share on Facebook Share on Linkedin
A heart attack is caused when one of the coronary arteries becomes blocked with a clot.
If successful, the group's first-in-class medication would be able to target inflammation in CVD patients before it even occurs. 
READ MORE >

Featured Articles

Siemens Healthineers unveils 'truly revolutionary' AI-enabled echo system

The new-look system is able to evaluate a situation and anticipate what users may need next.

READ MORE >
Example of the Siemens Origin AI-automated cardiac ultrasound system performing auto contours and measurements after the AI sees what is being imaged and the operator hits the AI button on the console. The system is designed to be an assistant to the operator and knows the next steps in the exams.
Share on Twitter Share on Facebook Share on Linkedin

Siemens Healthineers unveils 'truly revolutionary' AI-enabled echo system

Share on Twitter Share on Facebook Share on Linkedin
Example of the Siemens Origin AI-automated cardiac ultrasound system performing auto contours and measurements after the AI sees what is being imaged and the operator hits the AI button on the console. The system is designed to be an assistant to the operator and knows the next steps in the exams.
The new-look system is able to evaluate a situation and anticipate what users may need next.
READ MORE >

FDA panel votes not to endorse Medtronic renal denervation system

The vote was close, initially ending with a tie, but the panel ultimately decided there were too many questions related to the device's long-term benefits for patients with uncontrolled hypertension.

READ MORE >
The Medtronic Symplicity Spyral Renal Denervation system uses a catheter that curls in the renal artery to place radiofrequency electrodes against the vessel wall to ablate the nerves that control vasodilation, so the artery can be propped in the fully open position.
Share on Twitter Share on Facebook Share on Linkedin

FDA panel votes not to endorse Medtronic renal denervation system

Share on Twitter Share on Facebook Share on Linkedin
The Medtronic Symplicity Spyral Renal Denervation system uses a catheter that curls in the renal artery to place radiofrequency electrodes against the vessel wall to ablate the nerves that control vasodilation, so the artery can be propped in the fully open position.
The vote was close, initially ending with a tie, but the panel ultimately decided there were too many questions related to the device's long-term benefits for patients with uncontrolled hypertension.
READ MORE >

ESC Congress 2023: 4 key sessions scheduled for world’s largest gathering of cardiology professionals

The four-day event in Amsterdam officially begins on Friday, Aug. 25. Read our sneak preview of some of the conference's key sessions. 

READ MORE >
amsterdam the netherlands ESC Congress 2023
Share on Twitter Share on Facebook Share on Linkedin

ESC Congress 2023: 4 key sessions scheduled for world’s largest gathering of cardiology professionals

Share on Twitter Share on Facebook Share on Linkedin
amsterdam the netherlands ESC Congress 2023
The four-day event in Amsterdam officially begins on Friday, Aug. 25. Read our sneak preview of some of the conference's key sessions. 
READ MORE >

In Case You Missed It

New TAVR valve, premounted to save cardiologists time, linked to promising 30-day outcomes

The new valve arrives fully premounted on a delivery system and was designed to allow resheathing or complete recapture/redeployment if necessary. 

READ MORE >
Vienna Aortic Self-Expandable Transcatheter Valve premounted on the delivery system
Share on Twitter Share on Facebook Share on Linkedin

New TAVR valve, premounted to save cardiologists time, linked to promising 30-day outcomes

Share on Twitter Share on Facebook Share on Linkedin
Vienna Aortic Self-Expandable Transcatheter Valve premounted on the delivery system
The new valve arrives fully premounted on a delivery system and was designed to allow resheathing or complete recapture/redeployment if necessary. 
READ MORE >

AI model for HCM, the first of its kind, gains FDA approval

The new-look AI model was designed to automatically evaluate ECGs for signs of HCM and send alerts to the care team when necessary. 

READ MORE >
artificial intelligence robot evaluates healthcare data. Novo Nordisk announced a new collaboration with Valo Health, a healthcare technology company focused on using artificial intelligence (AI) technology to identify new drug treatments for cardiovascular disease (CVD).
Share on Twitter Share on Facebook Share on Linkedin

AI model for HCM, the first of its kind, gains FDA approval

Share on Twitter Share on Facebook Share on Linkedin
artificial intelligence robot evaluates healthcare data. Novo Nordisk announced a new collaboration with Valo Health, a healthcare technology company focused on using artificial intelligence (AI) technology to identify new drug treatments for cardiovascular disease (CVD).
The new-look AI model was designed to automatically evaluate ECGs for signs of HCM and send alerts to the care team when necessary. 
READ MORE >

In Other News

MRI results affected by movement? MIT researchers have an AI-powered solution

An MRI's sensitivity to movement during scans often leads to image artifacts, risking misdiagnoses and redundant scans. But a new deep learning model may be able to compensate.

READ MORE >
Motion-Corrected MRI Scan
Share on Twitter Share on Facebook Share on Linkedin

MRI results affected by movement? MIT researchers have an AI-powered solution

Share on Twitter Share on Facebook Share on Linkedin
Motion-Corrected MRI Scan
An MRI's sensitivity to movement during scans often leads to image artifacts, risking misdiagnoses and redundant scans. But a new deep learning model may be able to compensate.
READ MORE >

Solis Mammography acquiring network of breast imaging centers

Supported by Chicago-based Madison Dearborn Capital Partners, the company has grown rapidly in recent years to now include 100-plus locations.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Solis Mammography acquiring network of breast imaging centers

Share on Twitter Share on Facebook Share on Linkedin
Supported by Chicago-based Madison Dearborn Capital Partners, the company has grown rapidly in recent years to now include 100-plus locations.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
M&A activity in cardiology: Exploring key trends | Cardiac PET vs. SPECT | Doctors support Medicare covering TAVR for AR
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme
Trimed Popup